Kaye Edward M. MD: insider trades.
Kaye Edward M. MD reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($403K), across 2 companies.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 2
- Name as filed
- Kaye Edward M. MD
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | Director | 3 |
| Cytokinetics Inc (CYTK) | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-18 | Stoke Therapeutics, Inc. | S | 637 | $32.47 | 124,557 | Form 4 |
| 2026-08-18 | Stoke Therapeutics, Inc. | S | 11,930 | $32.01 | 125,194 | Form 4 |
| 2026-08-14 | Stoke Therapeutics, Inc. | M | 26,250 | $0 | 137,124 | Form 4 |
| 2026-07-15 | Cytokinetics Inc | A | 151 | $82.62 | 10,434 | Form 4 |
Questions
What stock did Kaye Edward M. MD buy or sell?
Kaye Edward M. MD reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($403K), across 2 companies.
Is Kaye Edward M. MD the same person as other filers with this name?
This page covers SEC CIK 1522780 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/kaye-edward-m-md-1522780.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.